TXG
10x Genomics Inc - Class A (TXG)
Healthcare • NASDAQ • $21.60-3.66%
- Symbol
- TXG
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Health Information Services
- Price
- $21.60
- Daily Change
- -3.66%
- Market Cap
- $2.79B
- Trailing P/E
- N/A
- Forward P/E
- 106.23
- 52W High
- $26.45
- 52W Low
- $8.07
- Analyst Target
- $24.46
- Dividend Yield
- N/A
- Beta
- 2.05
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium…
Company websiteResearch TXG on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.